Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Scopoderm 1.5mg Patch.
| Pharmaceutical Form |
|---|
|
Transdermal Patch. It is a flat, round reservoir patch approximately 1.8 cm in diameter. One side of the patch is tan; the other side is silver and is placed on an oversized clear hexagonal film. The unit is supplied in a flat, sealed, foil-lined, labelled unit dose packet. Each system has a contact surface area measuring 2.5cm² and hyoscine content of 1.5mg. The average amount of hyoscine absorbed from each system in 72 hours is 1mg. |
Each patch contains 1.5mg hyoscine U.S.P.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Scopolamine |
Scopolamine is a naturally occurring belladonna alkaloid and has anticholinergic properties. It acts as a competitive antagonist to acetylchloline and other parasympathomimetic agents. Its mechanism of action in the central nervous system in preventing motion sickness has yet to be elucidated. Scopolamine produces classical symptoms of parasympathetic blockade. |
| List of Excipients |
|---|
|
Drug Reservoir: Light mineral oil Backing Film: Pigmented MDPE/AL/PET/HS Film (vapour coated aluminised polyester with outer coating of pigmented medium density polyethylene (MDPE) and a heat sealable inner coating. Thickness 0.0686 mm. Release Controlling Membrane: Polypropylene Film. Thickness 0.0254 mm. Adhesive (to skin): Light mineral oil Release Liner (discarded before use): Silicone/Polyester Film |
Scopoderm – Individually packed into sealed paper laminated aluminium foil pouches. Outer cardboard carton containing two patches.
GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
PL 44673/0170
16 March 2004 / 02 March 2009
| Drug | Countries | |
|---|---|---|
| SCOPODERM | Estonia, Finland, France, Netherlands, New Zealand, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
